carpal tunnel syndrome. Carpal tunnel syndrome, unspecified upper limb
Conditions
Interventions
Intervention 1: Intervention group: Local ulnar in-plane injection of 1cc hyalouronic acid with 0/5 cc lidocaine 2% by ultrasound. Intervention 2: Control group: Local ulnar in-plane injection of 1cc
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients who suffer from mild or moderate carpal tunnel syndrome. Participants aged between 18 to 65 years Patients who had symptoms for at least 3 months
Exclusion criteria
Exclusion criteria: Women who were pregnant Participants who had severe carpal tunnel syndrome Patients who had past history of disorders like diabetes mellitus, thyroid dysfunction and rheumatoid arthritis Patients who had history of local injection of steroids within last 3 months Patients who had concomitant underlying neuropathy or radiculopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Median nerve size in ultrasound. Timepoint: Before intervention and 10 weeks after injection. Method of measurement: Cross section area of median nerve in inlet of carpal tunnel by ultrasound.;Pain. Timepoint: Before intervention and 10 weeks after injection. Method of measurement: Visual Analogue Scale.;Function. Timepoint: Before intervention and 10 weeks after injection. Method of measurement: Boston questionnaire.;Sensory and motor nerve conduction. Timepoint: Before intervention and 10 weeks after injection. Method of measurement: Nerve electrophysiologic study. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzieh Shakoori Arani
Shahid Beheshti University of Medical Sciences
Outcome results
None listed